Back to results
US 2003/0149269 A1Published application
Substituted piperidine derivatives
OwnerDuncan Robertson Rae, David Robert Jaapinventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to certain novel substituted piperidine derivatives, to processes for their preparation, to pharmaceutical formulations containing them and to their use in medical therapy, particularly in the treatment of psychotic disorders.
Claims10
A compound of formula (I)
- 7
- wherein R1 is benzothienyl, benzofuranyl, naphthyl (where the benzothienyl, benzofuranyl or naphthyl moiety may be optionally substituted by one or more substituents selected from halogen, C1-6alkyl, C3-6cycloalkyl, C1-6alkoxy and C2-6alkenyl), substituted-thienyl or substituted-furanyl (where the thienyl or furanyl moiety is substituted by one or more substituents selected from halogen, C1-6alkyl, C3-6cycloalkyl, C1-6alkoxy and C2-6alkenyl);
- R2 is substituted-phenyl or substituted-thienyl (where the phenyl or thienyl moiety is substituted by one or more substituents selected from C1-6alkyl and halogen);
- R3 is —(CH2)mXCONR4R5 or —(CH2)mNR6COR7 wherein R4 is hydrogen or C1-6alkyl and R5 is hydrogen, C1-6alkyl, C3-6cycloalkyl, C6-12aryl, C6-12aryl-C1-6alkyl or a C3-9heterocyclic group (where the alkyl, aryl or heterocyclic moiety may be optionally substituted by one or more substituents selected from halogen, C1-6alkyl, C3-6cycloalkyl, C1-6alkoxy and C2-6alkenyl) or R4 and R5 together with the nitrogen atom to which they are attached form a 4-10-membered heterocyclic group optionally substituted by one or more substituents selected from halogen, C1-6alkyl, C3-6cycloalkyl, C1-6alkoxy and C2-6alkenyl), R6 is hydrogen or C1-6alkyl, R7 is C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C6-12aryl, C6-12arylC1-6alkyl or a C3-9heterocyclic group (where the alkyl, aryl heterocyclic moiety may be optionally substituted by one or more substituents selected from halogen, C1-6alkyl, C3-6cycloalkyl, C1-6alkoxy and C2-6alkenyl), X is a bond, C6-12aryl or a 5- or 6-membered heteroaryl (where the aryl or heteroaryl moiety is optionally substituted by one or more substituents selected from halogen, C1-6alkyl, C3-6cycloalkyl, C1-6alkoxy and C2-6alkenyl);
- wherein m is an integer 1, 2, 3 or 4;
- or a pharmaceutically acceptable salt or solvate thereof.
3 more elements
Dependencies are inferred from the claim text.